CRISPR

CRISPR1-slco1d1

ID
ZDB-CRISPR-260821-5
Name
CRISPR1-slco1d1
Previous Names
None
Target
Sequence
5' - GGACTCGCATTTGTAAGGCA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
The first "G" was added.
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
rbi3 slco1d1
Expression
Gene expression in Wild Types + CRISPR1-slco1d1
No data available
Phenotype
Phenotype resulting from CRISPR1-slco1d1
No data available
Phenotype of all Fish created by or utilizing CRISPR1-slco1d1
Phenotype Fish Conditions Figures
vertebral column curved, abnormal slco1d1rbi3/rbi3 (ABO) chemical treatment by environment: perfluorooctane-1-sulfonic acid, chemical treatment by environment: 17beta-estradiol Fig. 7 from Vujica et al., 2026
whole organism dead, exacerbated slco1d1rbi3/rbi3 (ABO) chemical treatment by environment: perfluorooctane-1-sulfonic acid Fig. 1 from Vujica et al., 2026
swimming decreased occurrence, abnormal slco1d1rbi3/rbi3 (ABO) chemical treatment by environment: perfluorooctane-1-sulfonic acid Fig. 3 from Vujica et al., 2026
vertebral column curved, abnormal slco1d1rbi3/rbi3 (ABO) chemical treatment by environment: perfluorooctane-1-sulfonic acid Fig. 2 from Vujica et al., 2026
whole organism apoptotic, abnormal slco1d1rbi3/rbi3 (ABO) chemical treatment by environment: perfluorooctane-1-sulfonic acid Fig. 4 from Vujica et al., 2026
swim bladder deformed, abnormal slco1d1rbi3/rbi3 (ABO) chemical treatment by environment: perfluorooctane-1-sulfonic acid, chemical treatment by environment: 17beta-estradiol Fig. 7 from Vujica et al., 2026
digestive system necrotic, abnormal slco1d1rbi3/rbi3 (ABO) chemical treatment by environment: perfluorooctane-1-sulfonic acid, chemical treatment by environment: 17beta-estradiol Fig. 7 from Vujica et al., 2026
whole organism apoptotic process increased occurrence, abnormal slco1d1rbi3/rbi3 (ABO) chemical treatment by environment: perfluorooctane-1-sulfonic acid Fig. 4 from Vujica et al., 2026
brain necrotic, abnormal slco1d1rbi3/rbi3 (ABO) chemical treatment by environment: perfluorooctane-1-sulfonic acid, chemical treatment by environment: 17beta-estradiol Fig. 7 from Vujica et al., 2026
swim bladder deformed, exacerbated slco1d1rbi3/rbi3 (ABO) chemical treatment by environment: perfluorooctane-1-sulfonic acid Fig. 2 from Vujica et al., 2026
whole organism reactive oxygen species increased amount, abnormal slco1d1rbi3/rbi3 (ABO) chemical treatment by environment: perfluorooctane-1-sulfonic acid Fig. 4,  Fig. 6 from Vujica et al., 2026
Citations